Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Comprehensive Genomic Profiling Test

Rare Variants and the Prediction of Cancer Risk

Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients, Genome Medicine

A Simplified Framework for Workflow in Genetic Testing and Risk

Cancers, Free Full-Text

JPM, Free Full-Text

Frontiers Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis

Expanding cancer predisposition genes with ultra-rare cancer-exclusive human variations

Frontiers Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector